|
Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols Clinical research trials and Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols. Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols clinical trial. Subjects often receive the most expert healthcare possible for their Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols  Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols
Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols
For Condition: Central Nervous System Neoplasms
Status: Recruiting
Sponsor(s): National Cancer Institute (NCI) ,
Synopsis: The objective of this study is to evaluate patients with tumors of the central nervous system (CNS) for eligibility in the National Cancer Institute's research studies. These patients will undergo a series of procedures, usually including a complete medical history and physical examination; laboratory testing of blood, CSF, urine, bone marrow, or other samples; an evaluation of tumor location and size by x-rays, CT (computed tomography) or MRI (magnetic resonance imaging) scans, or nuclear medicine scans; lumbar puncture; electrocardiogram and echocardiogram; and procedures to evaluate the function of specific organs. A bone marrow biopsy is occasionally performed. Research samples may also be collected and stored to avoid having to do a painful test more than once. Tissue specimens collected during this process may be stored and used in future studies. Patients of both genders, any age, and all racial and ethnic groups with tumors of the CNS or a history of a CNS tumor are eligible. Up to 100 people are expected to participate. The physician will discuss the results of these procedures with the patient and his or her family. On the basis of the eligibility screening and the patient's wishes, the patient may then be enrolled in a primary research protocol.
Details: Patients with tumors of the central nervous system who are being evaluated by the Neuro-Oncology Branch (NOB) for National Cancer Institute (NCI) primary research protocols will be entered onto this screening protocol for eligibility screening. The screening tests and procedures that are required by the primary research protocols will be conducted in order to establish eligibility for these protocols. These procedures may include, but are not limited to, laboratory tests on blood, CSF, urine, or other specimens, and radiographic and nuclear medicine studies, which may require the administration of contrast or a radioisotopic tracer. In some cases, specific research samples required for the primary research protocol may be collected during the screening process in order to prevent us from having to subject the patient to a painful procedure on multiple occasions (e.g., bone marrow aspirations). These research specimens will be discarded, if the patient is not eligible for or elects not to enroll on the primary research protocol.
Eligibility:
Study Type: Observational, Screening
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Patients with tumors of the CNS or a history of a CNS tumor who are being evaluated for protocols within the National Cancer Institute. All patients or their legal guardians (if the patient is less than 18 years of age) must sign a document of informed consent indicating their understanding of the research nature and risks of the procedures that will be performed to assess eligibility for primary research protocols. When appropriate, pediatric patients (less than 18 years of age) will be included in all discussions in order to obtain verbal assent. A Durable Power of Attorney (DPA) will be offered to all patients greater than or equal to 18 years of age who have a brain tumor or meningeal tumor involvement. EXCLUSION CRITERIA:
Total Enrollment: 500
Location and Contact Information:
National Cancer Institute (NCI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 020186; 02-C-0186
Study Start Date: April 19, 2002
Record last reviewed: January 28, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035373
Other Central Nervous System Neoplasms Studies:
1. Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols
Related Studies:
Other Central Nervous System Neoplasms Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Eligibility Screening of Patients with Central Nervous System Tumors for the National Cancer Institute's (NCI) Clinical Research Protocols
|
|
|
|
|
|
|
|
